Skip to main content
INNV
NASDAQ Life Sciences

Q1 Revenue Up 12% to $264.8M, Net Income Nearly Triples to $20.9M

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.85
Mkt Cap
$1.208B
52W Low
$3.935
52W High
$12.64
52W Position info
125% above low
Off High info
30% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

INNV has more than doubled off its 52-week low of $3.935.

Summary

InnovAge opened fiscal 2027 with revenue of $264.8M, up 12.1% from $236.1M a year ago, and net income of $20.9M versus $7.7M — EPS of $0.14 against $0.06. Adjusted EBITDA nearly doubled to $31.3M (11.8% margin) from $17.6M (7.5%), and center-level contribution margin rose to 24.0% from 21.8%. Census grew to roughly 8,420 participants from 7,890. The company confirmed, rather than raised, its fiscal 2027 guidance of $1.050B-$1.085B revenue and $105M-$115M Adjusted EBITDA, so the beat is in the quarter, not the outlook. This follows the September 8 disclosure of 16% fiscal 2026 revenue growth to $989.7M with a $37M litigation accrual still hanging over the balance sheet. Cash stands at $119.3M plus $43.7M in short-term investments against $61.4M of debt. The 5:00 PM ET call is the next checkpoint for margin durability and any commentary on the shift to year-over-year comparisons.

At the time of this announcement, INNV was trading at $8.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $3.94 to $12.64. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

INNV - Latest Insights

INNV
Nov 03, 2026, 5:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.18 info
Change: +$0.330 (+4%) info
Market Cap: $1.259B info
INNV
Nov 03, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.85
Real-time Price: $9.18 info
Change: +$0.330 (+4%) info
Market Cap: $1.259B info
INNV
Sep 23, 2026, 2:46 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $9.65
Real-time Price: $9.18 info
Change: -$0.470 (-5%) info
Market Cap: $1.259B info
INNV
Sep 22, 2026, 5:19 PM EDT
Filing Type: 424B7
Importance Score:
7
Price at Filing: $9.51
Real-time Price: $9.18 info
Change: -$0.330 (-3%) info
Market Cap: $1.259B info
INNV
Sep 22, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $10.10
Real-time Price: $9.18 info
Change: -$0.920 (-9%) info
Market Cap: $1.259B info